Skip to main content
SpringerLink
Log in

Prevalence of Factor V Leiden-G1691A and MTHFR-C677T Thrombosis Gene Modifier in Iron Deficiency Anemia: A Pathophysiological Effect in Indian Isolates

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Normal iron levels are required to prevent thrombocytosis by inhibiting thrombopoiesis. Thrombocytosis is usually associated with a mild iron deficiency and is the result of a lack of inhibition of thrombopoiesis. Study participants were 430 iron deficiency anemia (IDA) patients. Ten (10) mL of venous blood were collected for the subjects. Ferritin analysis was done by ELISA method while Hemogram analysis was done by auto-analyzer. Factor V Leiden, PRTG20210A, and MTHFR C677T genotype analysis was performed by PCR–RFLP method. Among the patients, 9 were heterozygous (G>A) and 2 were homozygous (A>A) carrier of FV Leiden; while 20 were heterozygous (C>T) and 3 were homozygous (T>T) for MTHFR polymorphism. None of the patient was identified with PT mutation. Patients with thrombosis gene marker had lower hemoglobin, mean corpuscular volume, mean corpuscular haemoglobin levels, and mean corpuscular hemoglobin concentration than patients without thrombosis gene marker. Serum ferritin was elevated in subject with the absence of thrombosis gene markers. Our data suggest a high impact of inherited hypercoagulability risk factors in the pathogenesis of IDA and its complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kuku I, Kaya E, Yologlu S, Gokdeniz R, Baydin A. Platelet counts in adults with iron deficiency anemia. Platelets. 2009;20(6):401–5.

    Article  CAS  PubMed  Google Scholar 

  2. Karpatkin S, Garg S, Freedman M. Role of iron as a regulator of thrombopoiesis. Am J Med. 1974;57:521–5.

    Article  CAS  PubMed  Google Scholar 

  3. Beguin Y. Erythropoietin and platelet production. Haematologica. 1999;84:541–7.

    CAS  PubMed  Google Scholar 

  4. Dan K. Thrombocytosis in iron deficiency anemia. Intern Med. 2005;44:1025–6.

    Article  PubMed  Google Scholar 

  5. Tekin D, Yavuzer S, Tekin M, Akar N, Cin S. Possible effects of antioxidant status on increased platelet aggregation in childhood iron-deficiency anemia. Pediatr Int. 2001;43:74–7.

    Article  CAS  PubMed  Google Scholar 

  6. Akins PT, Glenn S, Nemeth PM, Derdeyn CP. Carotid artery thrombus associated with severe iron-deficiency anemia and thrombocytosis. Stroke. 1996;27:1002–5.

    Article  CAS  PubMed  Google Scholar 

  7. Hartfield DS, Lowry NJ, Keene DL, Yager JY. Iron deficiency: a cause of stroke in infants and children. Pediatr Neurol. 1997;16:50–3.

    Article  CAS  PubMed  Google Scholar 

  8. Kinoshita Y, Taniura S, Shishido H, Nojima T, Kamitani H, Watanebe T. Cerebral venous sinus thrombosis associated with iron deficiency: two case reports. Neurol Med Chir. 2006;46:589–93.

    Article  Google Scholar 

  9. Bertina RM, Koeleman BP, Koster T. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64–7.

    Article  CAS  PubMed  Google Scholar 

  10. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 30-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88(10):3698–703.

    CAS  PubMed  Google Scholar 

  11. Hanson NQ, Aras O, Yang F, Tsai MY. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem. 2001;47(4):661–6.

    CAS  PubMed  Google Scholar 

  12. Zimmerman SA, Ware RE. Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease. Am J Hematol. 1998;59(4):267–72.

    Article  CAS  PubMed  Google Scholar 

  13. Andrade FL, Annichino-Bizzacchi JM, Saad ST, Costa FF, Arruda VR. Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil. Am J Hematol. 1998;59(1):46–50.

    Article  CAS  PubMed  Google Scholar 

  14. Kutlar F, Tural C, Park D, Markkowitz RB, Woods KF, Kutlar A. MTHFR (5,10-methylenetetrahydrofolare reductase) 677 C-T mutation as a candidate risk factor for avascular necrosis (AVN) in patients with sickle cell disease. Blood. 1998;82(10):695a.

    Google Scholar 

  15. Ganti AK, Shonka NA, Haire WD. Pancytopenia due to iron deficiency worsened by iron infusion: a case report. J Med Case Rep. 2007;1:175.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Franchini M, Targher G, Montagnana M, Lippi G. Iron and thrombosis. Ann Hematol. 2008;87(3):167–73.

    Article  CAS  PubMed  Google Scholar 

  17. Stolz E, Valdueza JM, Grebe M, Schlachetzki F, Schmitt E, Madlener K, et al. Anemia as a risk factor for cerebral venous thrombosis? An old hypothesis revisited: results of a prospective study. J Neurol. 2007;254:729–34.

    Article  PubMed  Google Scholar 

  18. Racke F. EPO and TPO sequences do not explain thrombocytosis in iron deficiency anemia. J Pediatr Hematol Oncol. 2003;25:919–20.

    Article  PubMed  Google Scholar 

  19. Geddis AE, Kaushansky K. Cross-reactivity between erythropoietin and thrombopoietin at the level of Mpl does not account for the thrombocytosis seen in iron deficiency. J Pediatr Hematol Oncol. 2003;25:919–20.

    Article  PubMed  Google Scholar 

  20. Pandey SK, Meena A, Kishor K, Mishra RM, Pandey S, Saxena R. Prevalence of Factor V Leiden G1691A, MTHFR C677T, and prothrombin G20210A among Asian Indian sickle cell patients. Clin Appl Thromb Hemost. 2012;18(3):320–3.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Sincere thanks to Prof. U.K Chauhan for support.

Financial Assistance

Indian Council of Medical Research, New Delhi.

Author information

Authors and Affiliations

  1. Faculty of Life Sciences, School of Environmental Biology, Centre for Biotechnology Studies, Awadhesh Pratap Singh University, Rewa, M.P., 486003, India

    S. K. Pandey & S. Pandey

  2. Department of Environmental Biology, Awadhesh Pratap Singh University, Rewa, M.P., 486003, India

    R. M. Mishra

  3. Department of Medicine, SS Medical College, Rewa, 486001, India

    M. Indurkar

Authors
  1. S. K. Pandey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Pandey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. M. Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Indurkar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. K. Pandey.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pandey, S.K., Pandey, S., Mishra, R.M. et al. Prevalence of Factor V Leiden-G1691A and MTHFR-C677T Thrombosis Gene Modifier in Iron Deficiency Anemia: A Pathophysiological Effect in Indian Isolates. Ind J Clin Biochem 32, 103–105 (2017). https://doi.org/10.1007/s12291-016-0577-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-016-0577-6

Keywords

Search

Navigation